Phase I and phase II safety and efficacy trial of intercellular adhesion molecule-1 antisense oligodeoxynucleotide (ISIS 2302) for the prevention of acute allograft rejection.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples